A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy
This study is currently recruiting participants.
Verified June 2013 by Thomas Jefferson University
Sponsor:
Thomas Jefferson University
Information provided by (Responsible Party):
Thomas Jefferson University
ClinicalTrials.gov Identifier:
NCT00359320
First received: August 1, 2006
Last updated: June 4, 2013
Last verified: June 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this trial is to determine whether a mucosa-to-mucosa technique of pancreaticojejunostomy will improve the pancreatic fistula rate.
| Condition | Intervention |
|---|---|
|
Pancreatic Neoplasms Biliary Tract Neoplasms Pancreatitis, Chronic Duodenal Neoplasms |
Procedure: pancreaticojejunostomy |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy |
Resource links provided by NLM:
Further study details as provided by Thomas Jefferson University:
Primary Outcome Measures:
- The primary endpoint will be the pancreatic fistula rate.
Secondary Outcome Measures:
- length of hospitalization
- percutaneous intervention rates
- reoperation rates
- morbidity
- death
| Study Start Date: | July 2006 |
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Patients must have undergone pancreaticoduodenectomy.
- Must have pancreatic remnant remaining in place (body and tail).
- Must be candidate for reconstruction by pancreaticojejunostomy by one of the two techniques described below.
- Must have an identifiable pancreatic duct which can be used for a duct-to-mucosa anastomosis.
Exclusion Criteria:
- Patients undergoing total pancreatectomy.
- Patients undergoing PD who have had previous left-sided pancreatic resection.
- Failure to sign informed consent.
- Failure to identify the pancreatic duct.
- Pregnant patients.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00359320
Contacts
| Contact: Adam C Berger, MD | 215-955-1622 | adam.berger@jefferson.edu |
Locations
| United States, Pennsylvania | |
| Thomas Jefferson University Hospital | Recruiting |
| Philadelphia, Pennsylvania, United States, 19107 | |
| Sub-Investigator: Charles Yeo, MD | |
| Sub-Investigator: Eugene P Kennedy, MD | |
| Sub-Investigator: Ernest Rosato, MD | |
| Sub-Investigator: Karen Chojnacki, MD | |
| Sub-Investigator: Cataldo Doria, MD | |
| Sub-Investigator: Bernadette Profeta, MD | |
| Sub-Investigator: Patricia Sauter, CRNP | |
Sponsors and Collaborators
Thomas Jefferson University
Investigators
| Principal Investigator: | Adam C Berger, MD | Thomas Jefferson University |
More Information
No publications provided by Thomas Jefferson University
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Thomas Jefferson University |
| ClinicalTrials.gov Identifier: | NCT00359320 History of Changes |
| Obsolete Identifiers: | NCT00432848 |
| Other Study ID Numbers: | 06U.198 |
| Study First Received: | August 1, 2006 |
| Last Updated: | June 4, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Thomas Jefferson University:
|
Pancreaticoduodenectomy Pancreaticojejunostomy Pancreatic Cancer |
Additional relevant MeSH terms:
|
Biliary Tract Neoplasms Neoplasms Duodenal Neoplasms Pancreatic Neoplasms Pancreatitis Pancreatitis, Chronic Digestive System Neoplasms Neoplasms by Site Biliary Tract Diseases |
Digestive System Diseases Intestinal Neoplasms Gastrointestinal Neoplasms Gastrointestinal Diseases Duodenal Diseases Intestinal Diseases Endocrine Gland Neoplasms Pancreatic Diseases Endocrine System Diseases |
ClinicalTrials.gov processed this record on June 18, 2013